Koizumi M, Endo K, Sakahara H, Nakashima T, Nakano Y, Nakao K, Torizuka K
Acta Radiol Diagn (Stockh). 1986 May-Jun;27(3):305-9. doi: 10.1177/028418518602700310.
In order to evaluate the usefulness of computed tomography (CT) and 131I meta-iodobenzylguanidine (131I-MIBG) scintigraphy for the localization of pheochromocytoma, a prospective study was undertaken in 23 patients with possible pheochromocytoma. Seventeen tumors were identified in 13 patients. Two tumors were extra-adrenal. CT was superior for locating tumors in the adrenal glands while 131I-MIBG scintigraphy was more useful in the detection of extra-adrenal pheochromocytoma. Together with adrenal and extra-adrenal pheochromocytoma, the sensitivity for locating the tumor was calculated as 82 per cent (14/17) for CT and 76 per cent (13/17) for 131I-MIBG scintigraphy, respectively. One adrenal tumor (1 cm in size) only was missed by both methods. No false positive CT scans of 131I-MIBG scintigraphy were obtained in the remaining 10 patients who had possible pheochromocytoma but were excluded. These results indicated that CT and 131I-MIBG scintigraphy were both useful tools for detecting pheochromocytoma.
为评估计算机断层扫描(CT)和¹³¹I间碘苄胍(¹³¹I-MIBG)闪烁扫描术对嗜铬细胞瘤定位的有效性,对23例疑似嗜铬细胞瘤患者进行了一项前瞻性研究。13例患者中发现了17个肿瘤。2个肿瘤位于肾上腺外。CT在定位肾上腺肿瘤方面更具优势,而¹³¹I-MIBG闪烁扫描术在检测肾上腺外嗜铬细胞瘤方面更有用。结合肾上腺和肾上腺外嗜铬细胞瘤,CT定位肿瘤的敏感性计算为82%(14/17),¹³¹I-MIBG闪烁扫描术为76%(13/17)。两种方法均遗漏了1个肾上腺肿瘤(大小为1厘米)。在其余10例疑似嗜铬细胞瘤但被排除的患者中,未获得CT或¹³¹I-MIBG闪烁扫描术的假阳性结果。这些结果表明,CT和¹³¹I-MIBG闪烁扫描术都是检测嗜铬细胞瘤的有用工具。